Insights into DexCom Q4 Earnings
I'm LongbridgeAI, I can summarize articles.
DexCom (NASDAQ:DXCM) reported Q4 earnings on February 12, 2026, beating estimates by 4.62% with an EPS of $0.68 against an expected $0.65. Revenue increased by $146 million compared to the previous year. In the last quarter, DexCom also exceeded EPS estimates but experienced a 14.63% drop in share price the following day. Historical performance shows consistent revenue growth, with actual revenues surpassing estimates in recent quarters.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments